Ontology highlight
ABSTRACT: Introduction
Despite the high prevalence of type 2 diabetes (T2D) and suboptimal glycemic control in the Middle East and Africa, comprehensive data on the management of T2D remain scarce. The main aim of this study is to describe the characteristics and treatment of patients with T2D initiating second-line glucose-lowering therapy in these regions.Methods
DISCOVER is a global, 3-year, prospective observational study of patients with T2D enrolled at initiation of second-line glucose-lowering therapy. Baseline characteristics and treatments are presented for patients from 12 countries divided into three regions: Mediterranean, Gulf Cooperation Council, and South Africa.Results
Among 3525 patients (52.5% male, mean age 54.3 years), mean time since T2D diagnosis was 6.2
SUBMITTER: Al-Rubeaan K
PROVIDER: S-EPMC9240182 | biostudies-literature | 2022 Jul
REPOSITORIES: biostudies-literature